CompletedNot Applicable

Perioperative Supplementation With Immunonutrition and Its Impact on Surgical Outcome and Pain in Oral Cavity or Mandibular Tumours

Egypt176 participantsStarted 2023-02-01

Plain-language summary

The aim of this study was to investigate the effect of adding omega 3 and dipeptiven to standard feeding in head and neck patients who will undergo oral cavity tumour resection or mandibular tumour resection (immunonutrrition mixture) on wound infection, fistula formation and length of hospital stay ,total dose of intraoperative and postoperative opioids (opioid consumption and pain incidence ,mortality and other postoperative complications as urinary tract infection (UTI) and pneumonia.

Who can participate

Age range18 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age between 18 and 60 years. * Both sexes. * American Society of Anesthesiologists (ASA) physical status I or II . * Patient undergoing mandibular or oral cavity tumour resection. * Body mass index (BMI) between 18.5-24.9. * Patient with serum albumen above 3 gm. * Patient with written valid consent Exclusion Criteria: * Patient refusal and uncooperative patients. * Patient ASA III or IV. * Age more than 60 or less than 18. * Serum albumen less than 3. * Pre-existing severe malnourishment. * Allergy to test drugs. * Patients on tranquilizers, hypnotics, sedatives and other psychotropic patient on steroids and NSAID.

What they're measuring

The incidence of wound infection

Timeframe: 28 days after intervention

Trial details

NCT IDNCT06339372

SponsorCairo University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-08-01

View on ClinicalTrials.gov More Immunonutrition trials